STOCK TITAN

Pharvaris (PHVS) holder Berndt Modig files to sell 2,292 shares

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PHVS shareholder Berndt B.A.E. Modig has filed to sell up to 2,292 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated aggregate value of $80,380.44 for a planned trade date of July 13, 2026. The shares relate to Restricted Stock Units dated July 11, 2026 and the filing also lists prior Rule 10b5-1 sales in April, May, and June 2026 of about 2,291–2,292 shares each, with aggregate values between $65,558.53 and $71,172.89.

Positive

  • None.

Negative

  • None.

Filing Explained

The July 13 filing reports a proposed 2,292-share disposition, not a completed sale, with no disclosed issuer-level proceeds or dilution.

This Form 144 lists 2,292 common shares associated with restricted stock units as securities to be sold, so the disclosure is a proposed filer disposition rather than a reported completed sale; it does not disclose issuer proceeds or a change to outstanding shares.

The filing gives July 11, 2026 as the relevant date for the listed securities and identifies the issuer as the source of the restricted stock units.

It also lists three earlier sales—2,291, 2,292, and 2,292 shares—as 10b5-1 sales.

A Rule 10b5-1 plan is a written trading plan adopted in advance that executes trades on a schedule or formula, and the filing disclosing one states its adoption date rather than the reasons for individual trades.

Unlike those three historical entries, the current proposed-sale entry does not disclose a 10b5-1 plan.

Planned shares to be sold 2,292 shares Proposed sale of PHVS common stock via broker on or about July 13, 2026
Aggregate value of planned sale $80,380.44 Indicated aggregate value for 2,292 PHVS common shares in proposed transaction
April 16, 2026 Rule 10b5-1 sale 2,292 shares; $65,558.53 PHVS common stock sold under Rule 10b5-1 on April 16, 2026
May 15, 2026 Rule 10b5-1 sale 2,292 shares; $68,581.68 PHVS common stock sold under Rule 10b5-1 on May 15, 2026
June 15, 2026 Rule 10b5-1 sale 2,291 shares; $71,172.89 PHVS common stock sold under Rule 10b5-1 on June 15, 2026
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 10b5-1 regulatory
"10b5-1 Sales for Berndt B.A.E. Modig Emmy Noetherweg 2 Leiden"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Restricted Stock Units financial
"Common | 07/11/2026 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the PHVS Form 144 filing by Berndt B.A.E. Modig disclose?

The Form 144 shows that Berndt B.A.E. Modig plans to sell up to 2,292 PHVS common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an indicated aggregate value of $80,380.44 and a planned trade date of July 13, 2026.

How many PHVS shares are proposed to be sold in this Form 144?

The filing covers a proposed sale of 2,292 PHVS common shares. These shares are associated with Restricted Stock Units dated July 11, 2026, and are to be sold via Morgan Stanley Smith Barney LLC Executive Financial Services.

What is the aggregate value of PHVS shares in the planned Form 144 sale?

The Form 144 indicates an aggregate value of $80,380.44 for the 2,292 PHVS common shares proposed to be sold on or about July 13, 2026 on NASDAQ through Morgan Stanley Smith Barney LLC.

Which broker is handling the planned PHVS share sale for Berndt B.A.E. Modig?

The planned PHVS share sale is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, 8th Floor, New York, NY 10004, as disclosed in the Form 144 filing.

What prior PHVS sales are reported in the last 3 months in this Form 144?

The filing lists three prior Rule 10b5-1 PHVS sales: 2,292 shares on April 16, 2026 for $65,558.53; 2,292 shares on May 15, 2026 for $68,581.68; and 2,291 shares on June 15, 2026 for $71,172.89.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature